Did our pharmacological strategy for COVID-19 fail?

Pharmacol Res Perspect. 2021 Dec;9(6):e00866. doi: 10.1002/prp2.866.

Authors

Jennifer H Martin¹, Michelle Baddeley², Richard Head³

Affiliations

¹ University of Newcastle, Hunter Medical Research Institute, New Lambton, New South Wales, Australia.
² University of Technology Sydney, Ultimo, New South Wales, Australia.
³ University of South Australia, Clinical & Health Sciences Adelaide, South Australia, Australia.

No abstract available

Keywords: COVID-19; cognitive bias; observational study; renin angiotensin system; statins.

Publication types

Editorial
Comment

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
COVID-19*
Humans
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors